Do Recordati Industria Chimica e Farmaceutica's (BIT:REC) Earnings Warrant Your Attention?
Dec 18
Have your own idea? Try our Stock Screener
Italian (Borsa Italiana) Healthcare Sector Analysis
UpdatedDec 18, 2024
DataAggregated Company Financials
Companies19
- 7D-1.5%
- 3M-1.9%
- 1Y-0.9%
- YTD-2.0%
Over the last 7 days, the Healthcare industry has dropped 1.0%, driven by DiaSorin declining 2.0%. As for the longer term, the industry's performance has been flat for the past year. Looking forward, earnings are forecast to grow by 11% annually.
Sector Valuation and Performance
Has the Italian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 18 Dec 2024 | €24.2b | €19.0b | €1.4b | 18.5x | 17x | 1.3x |
| Fri, 15 Nov 2024 | €24.7b | €19.0b | €1.4b | 18.3x | 17.3x | 1.3x |
| Sun, 13 Oct 2024 | €25.5b | €18.9b | €1.4b | 17.8x | 18.5x | 1.3x |
| Tue, 10 Sep 2024 | €25.5b | €18.9b | €1.4b | 14.8x | 18.4x | 1.4x |
| Thu, 08 Aug 2024 | €25.0b | €18.9b | €1.4b | 16.2x | 18x | 1.3x |
| Sat, 06 Jul 2024 | €25.6b | €18.8b | €1.4b | 17x | 18.5x | 1.4x |
| Mon, 03 Jun 2024 | €26.1b | €18.8b | €1.4b | 17.5x | 18.8x | 1.4x |
| Wed, 01 May 2024 | €25.6b | €18.7b | €1.4b | 19.6x | 18.6x | 1.4x |
| Fri, 29 Mar 2024 | €25.9b | €18.6b | €1.4b | 20.2x | 18.6x | 1.4x |
| Sun, 25 Feb 2024 | €25.9b | €18.6b | €1.4b | 18.7x | 18.6x | 1.4x |
| Tue, 23 Jan 2024 | €24.1b | €18.6b | €1.4b | 18.5x | 17.3x | 1.3x |
| Thu, 21 Dec 2023 | €24.7b | €18.6b | €1.4b | 18.4x | 17.7x | 1.3x |
| Sat, 18 Nov 2023 | €23.0b | €18.6b | €1.4b | 19.9x | 16.5x | 1.2x |
| Mon, 16 Oct 2023 | €22.7b | €18.6b | €1.4b | 17.2x | 15.7x | 1.2x |
| Wed, 13 Sep 2023 | €23.3b | €17.3b | €1.1b | 15.2x | 20.5x | 1.3x |
| Fri, 11 Aug 2023 | €23.8b | €7.8b | €857.9m | 18x | 27.7x | 3.1x |
| Sun, 09 Jul 2023 | €22.9b | €7.7b | €822.5m | 16.4x | 27.9x | 3x |
| Tue, 06 Jun 2023 | €24.2b | €7.7b | €822.5m | 21.2x | 29.4x | 3.1x |
| Thu, 04 May 2023 | €24.4b | €7.6b | €825.6m | 21.8x | 29.5x | 3.2x |
| Sat, 01 Apr 2023 | €23.1b | €7.5b | €823.6m | 21.6x | 28x | 3.1x |
| Mon, 27 Feb 2023 | €23.3b | €7.5b | €867.3m | 24.2x | 26.8x | 3.1x |
| Wed, 25 Jan 2023 | €23.9b | €7.4b | €886.1m | 23.4x | 27x | 3.2x |
| Fri, 23 Dec 2022 | €23.4b | €7.4b | €886.1m | 22.2x | 26.4x | 3.1x |
| Sun, 20 Nov 2022 | €24.0b | €7.4b | €886.1m | 21.5x | 27.1x | 3.2x |
| Tue, 18 Oct 2022 | €21.8b | €7.3b | €908.8m | 19.1x | 24x | 3x |
| Thu, 15 Sep 2022 | €23.5b | €7.2b | €892.0m | 22.2x | 26.4x | 3.3x |
| Sat, 13 Aug 2022 | €25.9b | €7.2b | €887.4m | 23.6x | 29.2x | 3.6x |
| Mon, 11 Jul 2022 | €26.0b | €6.9b | €957.4m | 22x | 27.2x | 3.8x |
| Wed, 08 Jun 2022 | €24.5b | €6.9b | €957.8m | 21x | 25.5x | 3.6x |
| Fri, 06 May 2022 | €26.9b | €6.8b | €952.8m | 21.8x | 28.2x | 3.9x |
| Sun, 03 Apr 2022 | €30.4b | €6.7b | €952.0m | 24.6x | 31.9x | 4.5x |
| Tue, 01 Mar 2022 | €30.1b | €6.8b | €1.0b | 21.1x | 29.3x | 4.4x |
| Thu, 27 Jan 2022 | €31.2b | €6.8b | €1.0b | 21.6x | 30.5x | 4.6x |
| Sat, 25 Dec 2021 | €36.4b | €6.8b | €1.0b | 23.7x | 35.6x | 5.3x |
Price to Earnings Ratio
35.6x
Current Industry PE
- Investors are pessimistic on the Italian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 17.0x which is lower than its 3-year average PE of 23.7x.
- The 3-year average PS ratio of 2.6x is higher than the industry's current PS ratio of 1.3x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have grown 12% per year over the last three years.
- Revenues for these companies have grown 41% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Italian Healthcare sector?
| IT Market | -0.40% | |
| Healthcare | -1.46% | |
| Healthcare Services | -0.77% | |
| Pharma | -0.88% | |
| Biotech | -1.24% | |
| Life Sciences | -2.30% | |
| Medical Equipment | -2.96% | |
| Healthtech | -2.99% | |
Industry PE
- Investors are most optimistic about the Life Sciences industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 30.7%, which is lower than the prior year's growth of 672.9% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 35% over the next 5 years.
- However this is lower than its past earnings growth rate of 280% per year.
- In contrast, the Biotech industry is expected to see its earnings decline by 75% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PHIL Philogen | €18.75 | 0.3% +€2.0m | 3.9% | PS192.8x | |
| SVS Svas Biosana | €7.10 | 4.4% +€1.6m | -7.8% | PE7x | |
| PRL Pierrel | €1.75 | 0.6% +€549.3k | -61.9% | PE30.8x | |
| HI Health Italia | €131.00 | 1.6% +€374.0k | 1.6% | PE14.5x | |
| SHE Shedir Pharma Group | €4.88 | 0.4% +€227.3k | 7.5% | PE9.2x |
